CTOs on the Move

Dyax Corp.

www.dyax.com

 
Dyax Corp. (Dyax) is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million
  • www.dyax.com
  • 300 Technology Sq
    Cambridge, MA USA 02139-3515
  • Phone: 617.225.2500

Executives

Name Title Contact Details

Similar Companies

Lifeguard Digital Health

We are on the leading edge of research, development, clinical trials, and implementation of digital solutions that are aimed at harm reduction for various public health challenges. Our goal is to reduce harm and prevent unintentional deaths for people of all ages. Our team has pioneered apps that were developed in response to the opioid crisis, which is now a world-wide problem, as well as the COVID-19 pandemic and health & safety concerns in senior care centers.

InterGanics

InterGanics is a global solution-driven company that supports ingredients and finish products manufacturers to design an environmentally safe, socially responsible and economically sustainable sourcing strategy around Organic, Non-GMO and Specialty products.

Cellanyx

Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.

Reside Health

Reside Health is a membership-based medical and wellness practice that provides primary care and evidence-based wellness services to building occupants as an amenity.

Reliant Technologies

Reliant Technologies is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.